Acetic acid 7-acetoxy-4,9-dioxo-2,3,4,6,7,9-hexahydro-1H,5H-3a,4b,8,10-tetraaza-dicyclopenta[a,h]-s-indacen-1-yl ester

ID: ALA405158

PubChem CID: 44371836

Max Phase: Preclinical

Molecular Formula: C18H16N4O6

Molecular Weight: 384.35

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(=O)OC1CCn2c1nc1c2C(=O)c2c(nc3n2CCC3OC(C)=O)C1=O

Standard InChI:  InChI=1S/C18H16N4O6/c1-7(23)27-9-3-5-21-13-11(19-17(9)21)15(25)12-14(16(13)26)22-6-4-10(18(22)20-12)28-8(2)24/h9-10H,3-6H2,1-2H3

Standard InChI Key:  YUJREGITCKITCF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
    4.4167   -4.5042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8500   -4.5042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8500   -3.6792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4167   -3.6792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6375   -4.7625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6292   -4.7625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1292   -4.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6292   -3.4292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6375   -3.4292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1167   -4.1000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1542   -4.1000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1292   -3.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3667   -4.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9042   -4.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1167   -5.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1500   -5.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5875   -3.8792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6792   -3.8792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9042   -5.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3625   -5.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1292   -5.7417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1292   -2.4417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.3417   -4.2292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7542   -3.0500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0667   -2.5792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4125   -5.0542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.0167   -3.7625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5000   -2.6917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  7  1  0
  3  2  2  0
  4  1  2  0
  5  1  1  0
  6  2  1  0
  7  1  1  0
  8  3  1  0
  9  4  1  0
 10  6  1  0
 11  5  1  0
 12  4  1  0
 13 11  1  0
 14 10  1  0
 15  6  1  0
 16  5  1  0
 14 17  1  0
 13 18  1  0
 19 15  1  0
 20 16  1  0
 21  7  2  0
 22 12  2  0
 23 17  1  0
 24 18  1  0
 25 24  2  0
 26 23  2  0
 27 23  1  0
 28 24  1  0
  9 11  2  0
  3 12  1  0
 13 20  1  0
 10  8  2  0
 19 14  1  0
M  END

Associated Targets(Human)

Panel leukemia (Carcinoma cell lines) (209 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NSCLC (640 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Colon carcinoma cell (76 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNS carcinoma cell (76 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Melanoma cell (242 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ovarian carcinoma cell (138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Renal cancer cell line (72 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 384.35Molecular Weight (Monoisotopic): 384.1070AlogP: 0.87#Rotatable Bonds: 2
Polar Surface Area: 122.38Molecular Species: NEUTRALHBA: 10HBD:
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.11CX LogP: -0.56CX LogD: -0.56
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.60Np Likeness Score: 0.57

References

1. Schulz WG, Skibo EB..  (2000)  Inhibitors of topoisomerase II based on the benzodiimidazole and dipyrroloimidazobenzimidazole ring systems: controlling DT-diaphorase reductive inactivation with steric bulk.,  43  (4): [PMID:10691689] [10.1021/jm990210q]

Source